ArticleJournal of clinical immunology2021

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.

Jesús Troya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.